Surfactant as salvage therapy in life threatening primary graft dysfunction in lung transplantation

Amital, Anat; Shitrit, David; Raviv, Yael; Saute, Milton; Bakal, Ilana; Medalion, Benjamin; Kramer, Mordechai R.
February 2009
European Journal of Cardio-Thoracic Surgery;Feb2009, Vol. 35 Issue 2, p299
Academic Journal
Abstract: Objective: Impaired surfactant activity may contribute to primary graft dysfunction after lung transplantation. We assessed the role of surfactant treatment in lung transplant recipients with severe life threatening primary lung graft dysfunction. Patients and methods: Five patients after lung transplantation: 4 after single-lung transplantation, for emphysema (n =3) or idiopathic pulmonary fibrosis (n =1), and 1 patient after double-lung transplantation for cystic fibrosis. All had severe life threatening primary graft dysfunction that failed to respond to conventional measures. Treatment consisted of bronchoscopic instillation of mammalian surfactant, 20–90cc, at 3 (n =1) or 7 days (n =4) after transplantation. Results: There was a significant improvement in the ratio of partial arterial oxygen tension (PaO2) to fractional concentration of oxygen in inspired gas (FIO2), from a mean of 98.8±21.7 to 236.8±52.3mmHg (p =0.0006), within hours of treatment. All were eventually discharged home and showed a satisfactory FEV1 (44–67% predicted) at the 6-month follow-up. All patients were still alive 6 months or more after transplantation. Conclusion: Surfactant treatment improves oxygenation and may be life saving in patients with primary lung graft dysfunction.


Related Articles

  • Surfactant pretreatment decreases long-term damage after ischemia-reperfusion injury of the lung. van der Kaaij, Niels P.; Kluin, Jolanda; Haitsma, Jack J.; den Bakker, Michael A.; Lambrecht, Bart N.; Lachmann, Burkhard; de Bruin, Ron W.F.; Bogers, Ad J.J.C. // European Journal of Cardio-Thoracic Surgery;Feb2009, Vol. 35 Issue 2, p304 

    Abstract: Objective: Lung ischemia-reperfusion injury (LIRI) is a risk factor for primary acute graft failure following lung transplantation. LIRI hereby contributes to morbidity and mortality after lung transplantation. We have previously shown that surfactant pretreatment ameliorates LIRI up...

  • Heart-lung transplantation for cystic fibrosis. Higenbottam, T. W.; Whitehead, B. // Journal of the Royal Society of Medicine (Supplement);Jan1991, Vol. 84 Issue 18, p18 

    The article discusses the problems and potential of heart-lung transplantation (HLT) as a treatment for patients who have developed respiratory failure from cystic fibrosis (CF). The problem of chest wall bleeding which has contributed to fatalities in CF patients after HLT has been lessened by...

  • Gut oxygenation and oxidative damage during and after laparoscopic and open left-sided colon resection: a prospective, randomized, controlled clinical trial. Gianotti, Luca; Nespoli, Luca; Rocchetti, Simona; Vignali, Andrea; Nespoli, Angelo; Braga, Marco // Surgical Endoscopy;Jun2011, Vol. 25 Issue 6, p1835 

    Background: Pneumoperitoneum (PP), established for laparoscopic (LPS) operation, has been associated with potential detrimental effects, such as mesenteric ischemia-reperfusion injury. The objective of the trial was to measure intestinal tissue oxygen pressure (PO) and oxidative damage during...

  • Maxillary sinus surgery in maxillary sinusitis with cystic fibrosis. Erkan, Alper // European Archives of Oto-Rhino-Laryngology;Jun2013, Vol. 270 Issue 6, p1969 

    A letter to the editor is presented in response to the article "Posttransplant sinus surgery in lung transplant recipients with cystic fibrosis: a single institutional experience," by D. Vital and colleagues in the 2013 issue.

  • Aprotinin decreases reperfusion injury and allograft dysfunction in clinical lung transplantation Bittner, Hartmuth B.; Richter, Markus; Kuntze, Thomas; Rahmel, Axel; Dahlberg, Peter; Hertz, Marshall; Mohr, Friedrich W. // European Journal of Cardio-Thoracic Surgery;Feb2006, Vol. 29 Issue 2, p210 

    Abstract: Objective: Primary graft dysfunction caused by ischemia–reperfusion injury is one of the most frequent causes of early morbidity and death after lung transplantation. We hypothesized that the perioperative management with aprotinin decreases the incidence of allograft...

  • Hidden Suffering. Vallurupalli, Mounica; Vesel, Tamara // Journal of Palliative Medicine;Mar2012, Vol. 15 Issue 3, p362 

    A personal narrative is presented which explores the author's experience of how a sixteen-year-old girl inflicted with cystic fibrosis has taught her the importance of healing with deliberate understanding.

  • Hyperbaric oxygenation pretreatment induces catalase and reduces infarct size in ischemic rat myocardium. Chan-Hyung Kim; Hong Choi; Yang-Sook Chun; Gi-Tae Kim; Jong-Wan Park; Myung-Suk Kim // Pflugers Archiv European Journal of Physiology;Jul2001, Vol. 442 Issue 4, p519 

    Ischemia-reperfusion injury is a major complication occurring in heart stroke, cardiopulmonary bypass surgeries, and heart transplantation. Reactive oxygen species generated during the reperfusion phase overwhelm the scavenging capacities of antioxidant enzymes, and result in oxidative damage to...

  • What every pediatrician needs to know about lung transplants in children. Faro, Albert // Contemporary Pediatrics;Aug2000, Vol. 17 Issue 8, p61 

    Discusses indications, contraindications and other aspects concerning lung transplantation in children in the United States (U.S.). Number of pediatric lung and heart-lung transplant performed in the U.S. between 1987 and 1998; Two major types of lung transplant; Categories of immunosuppressants...

  • Extended donor criteria for lung transplantation–a clinical reality. Aigner, Clemens; Winkler, Guenther; Jaksch, Peter; Seebacher, Gernot; Lang, Gyorgy; Taghavi, Sharokh; Wisser, Wilfried; Klepetko, Walter // European Journal of Cardio-Thoracic Surgery;May2005, Vol. 27 Issue 5, p757 

    Abstract: Objective: Standard lung donor criteria have been established on opinions and individual experiences rather than on existing evidence. Since the scarcity of donor organs is one of the major limitations to lung transplantation, extension of donor lung criteria might considerably...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics